Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment and survival of patients with cancer of the prostate. The Veterans Administration Co-operative Urological Research Group.

× No keyword cloud information.

58 in total

Review 1. A history of prostate cancer treatment.

Authors: Samuel R Denmeade; John T Isaacs
Journal: Nat Rev Cancer Date: 2002-05 Impact factor: 60.716

2. The ultrastructure of the accessory sex organs of the male rat. 7. The effect of an anti-androgenic compound, SK and F 22340.

Authors: K J Tveter; E Dahl
Journal: Urol Res Date: 1975

3. Intralbugineous testicular prosthesis, a new technique. Summary of 30 implants.

Authors: R G Aguilera; J P López; R R Aldosa; G Rius-Espina
Journal: Int Urol Nephrol Date: 1990 Impact factor: 2.370

4. Complete androgen blockade as primary treatment for advanced metastatic cancer of the prostate.

Authors: J F Larsen; S Walter; T Krarup
Journal: Int Urol Nephrol Date: 1990 Impact factor: 2.370

5. Inhibition of aberrant androgen receptor induction of prostate specific antigen gene expression, cell proliferation and tumor growth by 17α-estradiol in prostate cancer.

Authors: Yaming Qiao; Lu Wang; Li-Qun Cai; Chen Tan; Julianne Imperato-McGinley; Yuan-Shan Zhu
Journal: J Urol Date: 2011-01 Impact factor: 7.450

6. Inhibition of androgen-independent prostate cancer by estrogenic compounds is associated with increased expression of immune-related genes.

Authors: Ilsa M Coleman; Jeffrey A Kiefer; Lisha G Brown; Tiffany E Pitts; Peter S Nelson; Kristen D Brubaker; Robert L Vessella; Eva Corey
Journal: Neoplasia Date: 2006-10 Impact factor: 5.715

Treatment and survival of patients with cancer of the prostate. The Veterans Administration Co-operative Urological Research Group.

Review 1. A history of prostate cancer treatment.

2. The ultrastructure of the accessory sex organs of the male rat. 7. The effect of an anti-androgenic compound, SK and F 22340.

3. Intralbugineous testicular prosthesis, a new technique. Summary of 30 implants.

4. Complete androgen blockade as primary treatment for advanced metastatic cancer of the prostate.

5. Inhibition of aberrant androgen receptor induction of prostate specific antigen gene expression, cell proliferation and tumor growth by 17α-estradiol in prostate cancer.

6. Inhibition of androgen-independent prostate cancer by estrogenic compounds is associated with increased expression of immune-related genes.

7. Early (stage A) prostatic cancer. IV. Methodological criteria for histopathological diagnosis.

Review 8. Screening for prostate cancer. Implications for drug therapy.

9. The current status of adjuvant hormonal therapy combined with radiation therapy for localised prostate cancer.

Review 10. Current concepts in the treatment of genitourinary tract disorders in the older individual.